Skip to main content
Clinical Trials/CTRI/2023/10/059309
CTRI/2023/10/059309
Not yet recruiting
Phase 2

A Randomized Controlled Clinical Study To Evaluate The Efficacy Of Mashbaladi Kwath Nasya in pakshaghat with special reference to hemiplegia due to thrombotic stroke. - nil

VD Neha Subhash Bari0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
VD Neha Subhash Bari
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VD Neha Subhash Bari

Eligibility Criteria

Inclusion Criteria

  • Patient between age group 20\-60 yrs irrespective of gender.
  • Patient having muscle power grade \< or 4
  • Patients of nonprogressive infraction diagnose by MRI or CT scan.
  • Patients of Pakshavadh of durations not more than 1 year.
  • Patient willing to participate in the study.
  • Patients who have not participated in any research project in last 6 months.
  • Patients having signs and symptoms of Pakshavadh mentioned by ayurveda as following Ruja Achetana Akarmanyata Hasta pada sankocha Hatpaksha

Exclusion Criteria

  • Patients with cerebral hemorrhagia.
  • Comatose and unconscious patients.
  • Pregnant and lactating mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials